Patent · US Active

Parenteral dosage form of norepinephrine

US11166923B2 · kind B2 · utility

0Cited by

4References

14Claims

0Family size

Assignee

SUN PHARMACEUTICAL INDUSTRIES LIMITED · IN

Inventors

Rakesh Thummar · Salumbar, IN
Shantaram Laxman Pawar · Salumbar, IN
Prashant Kane · Sayla, IN
Subhas Balaram Bhowmick · Salumbar, IN
Samarth Kumar · Salumbar, IN
Milan Natvarbhai THAKKAR · Salumbar, IN
Kandarp Maheshkumar DAVE · Salumbar, IN

Key dates

Filing date	Jan 19, 2018
Grant date	Nov 9, 2021
Priority date	—
Expiry date	Jan 19, 2038

Classification

Technology area (CPC Y)Emerging Cross-Sectional Technologies
CPC primaryY02A50/30
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention relates to a ready-to-administer parenteral dosage form of norepinephrine which comprises an aqueous solution of norepinephrine, having an anti-oxidant which is not a sulfite anti-oxidant, wherein the dosage form is stable at room temperature for prolonged period of time.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.